Cardioprotective effects of simvastatin on reversing electrical remodeling induced by myocardial ischemia-reperfusion in normocholesterolemic rabbits

Chinese Medical Journal

Volumn 121, Issue 6, 2008, Pages 551-556

  Ding, Chao ^a   Fu, Xiang Hua ^a   He, Zhen Shan ^a   Chen, Hui Xiao ^a   Xue, Ling ^a   Li, Jun Xia ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Ionic channel; Ischemia; Patch clamp techniques; Reperfusion; Simvastatin

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; CELL ISOLATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; ION CURRENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; RABBIT; REPERFUSION INJURY; SODIUM CURRENT;

EID: 41649120948     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803020-00017     Document Type: Article

References (23)

1. Mehta D, Curwin J, Gomes JA, Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation 1997; 96: 3215-3223.
2. Ding C, He ZS, Cui JY, Yang L, Shi Q, Hu LY, et al. Alteration of transient outward potassium current in ventricular myocytes from 1-week and 2-month infarcted rabbit hearts. Chin J Pathophysiol (Chin) 2004; 20: 1472-1475.
3. Chen J, Nagasawa Y, Zhu BM, Ohmori M, Harada K, Fujimura A, et al. Pravastatin prevents arrhythmias induced by coronary artery ischemia/ reperfusion in anesthetized normocholesterolemic rats. J Pharmacol Sci 2003; 93: 87-94.
4. Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol 2006, 97: 153-154.
5. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every W, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infaretion on early morbidity and mortality. Am J Cardiol 2005; 96: 611-616.
6. + currents in ventricular myocytes from two months infareted rabbit heart. Chin J Cardiac Pacing Electrophysiol (Chin) 2003; 17: 134-137.
7. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981; 391: 85-100.
8. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 1999; 100: 178-184.
9. Sotiriou CG, Cheng JW. Beneficial effects of statins in coronary artery disease-beyond lowering cholesterol. Ann Pharmacother 2000; 34: 1432-1439.
10. Fu XH, Fan WZ, Gu XS, Wei YY, Jiang YF, Wu WL, et al. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infaretion. Chin Med J 2007; 120: 1226-1231.
11. Han YL, Liang M, Jing QM, Wang SL, Wang ZL, Chen XH. Adjunctive anti-tachycardia pacing therapy for patients with acute myocardial infaretion during emergency percutaneous coronary intervention. Chin Med J 2005; 118: 691-694.
12. Zou LY, Jiang WP. Effect of ischemia/reperfusion on membrane ionic channels of guinea pig ventricular myocytes. Chin J Cardiac Pacing Electrophysiol (Chin) 1999; 13: 230-233.
13. Katra RP, Laurita KR. Cellular mechanism of calcium-mediated triggered activity in the heart. Circ Res 2005; 96: 535-542.
14. 2+ channel, GRK2, and phosphorylated phospholamban: protective mechanisms for the denervated failing heart. J Mol Cell Cardiol 2006; 40: 619-628.
15. Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP, AVID Investigators. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 2003; 42: 88-92.
16. Chan AW, Bhatt DL, Chew DP, Reginelli J, Schneider JP, Topol EJ. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 2003; 107: 1750-1756.
17. Wassmann S, Laufs U, Baumer AT, Muller K, Ahlbory K, Linz W. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001; 37: 1450-1457.
18. Rosenson RS, Tangney CC. Anti atherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998; 279: 1643-1650.
19. Wan MX, Schramm R, Klintman D, Welzenbach K, Weitz-Schmidt G, Thorlacius H. A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon. Br J Pharmacol 2003; 140: 395-401.
20. Ray JG, Gong Y, Sykora K, Tu JV. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med 2005; 165: 62-67.
21. Zhao JL, Yang YJ, Cui CJ, You SJ, Gao RL. Pretreatment with sirnvastatin reduces myocardial no-reflow by opening mitochondrial K (ATP) channel. Br J Pharmacol 2006; 149: 243-249.
22. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004; 110: 2313-2319.
23. Pehlivanidis AN, Athyros VG, Demitriadis DS, Papageorgiou AA, Bouloukos VJ, Kontopoulous AG. Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease. Atherosclerosis 2001; 157: 463-469.